About PPA   |   Sign In   |   Join Now
LCPA General Meeting and CE Event
Tell a Friend About This EventTell a Friend
LCPA General Meeting and CE Event

When: Tuesday, November 12
Where: Penn Medicine Lancaster General Health Suburban Pavilion, 3rd Floor Conference Center
2100 Harrisburg Pike
Lancaster, Pennsylvania  17604
United States
Presenter: Julia Ressler
Contact: Denise Alexander

Online registration is closed.
« Go to Upcoming Event List  

LCPA presents: Preventing & Responding to Opioid Overdose Emergencies
Tuesday, November 12th at 6:30 PM

Click here for a flyer about the event!


Location: Penn Medicine Lancaster General Health Suburban Pavilion, 3rd Floor Conference Center

                 2100 Harrisburg Pike

                 Lancaster, PA 17604



6:30 PM - Registration & Networking

6:30-7:00 PM - Dinner will be served

7:00 PM - CE begins (LCPA meeting will be after CE)


This event is FREE for PPA/LCPA members. Any non-member there is a charge of $10 to register, and an additional $50 if you are a pharmacist receiving CE credit at this event (Collected at event). This event is open to all but ONLY PHARMACISTS CAN RECEIVE CE.



Julia Ressler, MSW, MPH

Health Promotion Specialist at Penn Medicine Lancaster General Health


Target Audience: Pharmacists

CE Credit: 2 hour (0.2 CEUs)

Activity Type: Knowledge-based

UAN: 0159-0000-19-047-L05-P


Program objectives:

At the completion of this activity, the participant will be able to:

1. Understand what an opioid-related overdose is, what factors contribute to the risk of overdose, and how to
prevent an overdose
2. Identify naloxone, its different formulations, and how it works
3. Identify appropriate indicators for naloxone, as defined by the CDC and PA Department of Health
4. Understand the statewide standing order for naloxone and relevant state laws
5. Understand dispensing practices for naloxone, including application of the standing order, billing, distribution
of grant-funded naloxone kits, and how to counsel patients
6. Identify the signs and symptoms of an opioid-related overdose
7. Identify the steps to safely and effectively respond to an opioid-related overdose with naloxone
8. Identify community resources that can support individuals interested in accessing treatment or recovery
support services

Description: Pharmacists are a critical part of the healthcare system and ongoing efforts to improve patient safety and prevent opioid-related emergencies. As public awareness about opioid safety increases, pharmacies are increasingly dispensing and educating patients about naloxone (i.e. NARCAN ® Nasal Spray). This program will provide an overview of naloxone in addition to opioid-related overdose, risk factors for overdose, and how to respond to an overdose. This will increase pharmacist self-efficacy when providing education about these issues to patients.


Requirements to receive CE credit: Participants must be present for the entire program, sign the sign-in sheet, and complete an online evaluation survey within one week. PPA must have you CPE Monitor ID and birthday on file to issue credit.



Deadline for registrations is November 9th!


By registering and attending this event, I consent to being photographed as part of the event and any such photographic image being used in PPA promotional, print materials, website, videos, and/or social media.  PPA agrees to only use such images in a positive and tasteful manner.  If for any reason you do not wish to give this consent, please contact PPA in advance of the event.


The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Association Management Software Powered by YourMembership  ::  Legal